Several host molecules have been studied and evaluated as potential targets for the development of new host-directed therapies for TB with the aim of clearing Mtb infection more rapidly and effectively and HO-1 is one of these candidates [181]. This evidence concerns the gene HMOX1 and tuberculosis.